CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
Compassion and Metacognition Based Therapy +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04764708
NCT04764708N/ACompleted
CompareCT.gov

Compassion and Metacognition Based Therapy for Schizotypal Personality Disorder: A Pilot Non-inferiority Randomized Controlled Trial on Repeated Measures.

Tages Onlus·interventional·Posted Feb 21, 2021·Updated Jun 21, 2022

In Brief

A clinical study evaluating Compassion and Metacognition Based Therapy and Cognitive Behavioral Therapy for Schizotypal Personality Disorder. Completed, enrolled 16 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the safety and efficacy of a newly developed psychotherapy for schizotypal personality disorder. This new form of psychotherapy integrates compassion focused therapy and metacognitively oriented psychotherapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizotypal Personality Disorder
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 21, 2021
Enrollment StartDec 15, 2020
Primary CompletionSep 30, 2021
Study CompletionDec 20, 2021
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 5.4 years ago

Interventions

Compassion and Metacognition Based Therapybehavioral

The intervention is a Third Wave Cognitive Therapy targeting metacognitive dysfuctions (through Metacognitively Oriented Psychotherapy) and self-criticism (through Compassion Focused Therapy).

Cognitive Behavioral Therapybehavioral

Standard Cognitive Behavioral Therapy for Personality Disorders plus Standard Psychopharmacological Treatment.